Abbott India Ltd share price logo

Abbott India Ltd Share Price (ABBOTINDIA)


Get free price alerts. Set up your Free investment account to get Live Prices. >
Q2 '23 Results
News and Events

Overview of Abbott India Ltd

Key events for Abbott India Ltd

  • Sun Pharma, Abbott India and Torrent Pharma Lose Most Share - 17 Nov, 2023

    Abbott India Ltd is among the companies that lost the most share during the period.

  • Abbott India Q2 2024 Results Show Revenue Growth of 8.3% - 14 Nov, 2023

    Abbott India Ltd reported revenue of ₹14.9b in Q2 2024, up 8.3% YoY, with net income of ₹3.13b, up 18%. The profit margin increased to 21%, driven by higher revenue. EPS was ₹147. Abbott India's revenue is forecasted to grow at a rate of 12% p.a.

  • Abbott India Shares Fall Despite Strong Q2 Results - 13 Nov, 2023

    Abbott India reported a 17% YoY increase in Q2FY24 net profit, but shares fell by almost 3%. CLSA downgraded the stock to overweight and raised its target price.

  • General Public Holds 16% Ownership in Abbott India - 06 Oct, 2023

    Public companies own 75% of Abbott India stock, while the general public holds a 16% ownership. This group can have a real influence on how the company is run.

  • Abbott India Warns of Supply Shortages for Laxative Syrups - 25 Sep, 2023

    Abbott India Ltd has warned of potential supply shortages for two popular laxative syrups after production was prohibited in Goa state.

  • Abbott India Reports Growth in Financials - 21 Sep, 2023

    Abbott India Ltd has reported growth in revenue, net profits, and net margins over the last few FYs. The company also has a low debt to equity ratio of 0.00.

  • Abbott India Faces Manufacturing Issues in Goa Plant - 15 Sep, 2023

    Abbott India faces manufacturing issues at its Goa plant, leading to a recall of Digene Gel. The stock initially dipped but later recovered on news of corrective measures.

  • Goa State Plans to Suspend Abbott India's Manufacturing License - 14 Sep, 2023

    Abbott India faces suspension of its manufacturing license for antacid medicine due to contamination risks and sanitization issues at its Goa factory.

  • Abbott India Recalls Antacid Due to Safety Concerns - 06 Sep, 2023

    Abbott India has recalled several batches of antacid Digene Gel after the Drug Controller General of India (DCGI) issued an advisory against using the product. The impugned product may be unsafe and could result in adverse effects when consumed.

  • Abbott India's Share Price Soars and Gains Market Share - 14 Aug, 2023

    Abbott India Ltd's share price has seen significant growth over the past five years, with a TSR of 220%, while also gaining maximum share in the Indian pharma market.

  • Redcliffe Labs Collaborates with Abbott India to Introduce Clinical Decision Support - 13 Aug, 2023

    Abbott India has partnered with Redcliffe Labs to introduce clinical decision support (CDS) powered by Big Data Engines and AI, aimed at enhancing patient care and convenience.

  • Abbott India's Q2 Revenue Grows by 6% - 11 Aug, 2023

    India contributed 38% of Abbott India's total revenue for the quarter, with a 6% growth in revenue. Sales of active pharmaceutical ingredients rose 14%. Research and development investments stood at Rs 324 crore.

  • Abbott India Reports Strong Q1 Results - 10 Aug, 2023

    Abbott India Ltd's net profit for Q1 FY23 rose 41.2% YoY to Rs 290.20 crore, aided by a 13.4% increase in revenue and improved EBITDA margin.

  • Abbott India Reports Strong Q1 Results - 09 Aug, 2023

    Abbott India Ltd reports a strong Q1 FY24 with a 41.2% YoY increase in net profit and approval of new Company Secretary and Compliance Officer.

  • Abbott India Hits New High Amidst Fake Medicine Scandal - 04 Aug, 2023

    Abbott India Ltd's stock hit a new 52-week high of Rs 24,682.45 amidst the seizure of fake medicines of many leading pharma companies including Abbott.

  • Abbott India Stock Reaches All-Time High - 03 Aug, 2023

    Abbott India's stock price reached an all-time high of Rs 24,613.25 on August 3.

  • Abbott India Ltd to Trade Ex-Dividend on July 21, 2023 - 16 Jul, 2023

    Abbott India Ltd is set to trade ex-dividend on July 21, 2023. The company's next dividend payment will be ₹325 per share, which represents a trailing yield of 1.4% on the current share price of ₹23293.9. Abbott India's payout ratio is modest, at just 40% of profit, and the dividend is covered by both profits and cash flow, suggesting that it is sustainable.

  • Abbott India to Increase Dividend Payment - 15 Jul, 2023

    Abbott India Ltd will increase its dividend payment to Rs 325.00, with a sustained record of paying dividends and growing EPS at 19% per year over the past five years.

  • Abbott India Ltd to Hold Its 79th AGM Virtually - 14 Jul, 2023

    Abbott India Ltd will conduct its 79th Annual General Meeting virtually on August 9, 2023, covering the adoption of audited financial statements, declaration of dividends, appointment of directors, and ratification of remuneration payable to cost auditors.

  • Abbott India Ltd to Increase Dividend Payment - 01 Jul, 2023

    Abbott India Limited plans to increase its dividend payment to ₹325.00, taking the annual payment to 1.4% of the stock price, which is above what most companies in the industry pay. The company has a sustained record of paying dividends with very little fluctuation.

Analyst Rating for Abbott India Ltd stock

based on 9 analysts


Based on 9 analysts offering long term price targets for Abbott India Ltd. An average target of ₹24752.33

Source: S&P Global Market Intelligence

Abbott India Ltd share Performance

  • ₹23500
    downward going graph



    Day's Volatility:1.19%



    downward going graph
  • ₹19900
    downward going graph



    52 Weeks Volatility:20.58%



    downward going graph
1 Month Return5.41 %
3 Month Return1.21 %
1 Year Return17.49 %
Previous Close₹23,697.75
Market Cap₹50,357.72Cr

Abbott India Ltd Company Information

Abbott India Ltd is a leading multinational pharmaceutical company in India, with its headquarters in Mumbai. It has manufacturing facilities in Goa and independent contract/third party manufacturers based across the country. The company provides products and solutions across therapeutic areas such as Womens Health, Gastroenterology, Central Nervous System, Metabolics, MultiSpecialty, Vaccines and Consumer Health. In 2002, they sold their Jejuri Undertakings with assets and liabilities as a going concern. In 2003, they amalgamated Knoll Pharmaceuticals Ltd with the company. In 2004, they started capsule production with a capacity of 27 million nos. and in 2005, they further increased the capacity to 56 million nos. and started a new project of producing nutritional products with installed capacity of 600 tonnes. In 2006, the production capacity of Tablets was also increased by 236 million nos to 686 million. In 2008, they launched Digene Total buffered pantoprazole tablet, Bruge, and Thyronorm 150 Digene along with Sugar Free Tablet and Gel. In 2018, Abbott India Ltd formed a new Business Unit GI Advance which followed a Build Operate Transfer model. During the year 2020-21, the company made an innovation in Brufen Coating formula leading to 50% increase in coating installed capacity. It further executed 8 new studies and published 8 articles in major indexed journals. Abbott India also launched 10 new products in various therapy segments leading to their recognition as The Most Innovative MNC of the Year 2019 at the 12th Pharma Leaders Award. The Drug Price Control Order 2013 brought several products of Abbott India under price control, leading to an adverse impact on sales and profits. They also received approvals to conduct phase 3 studies in adults/eldery and pediatric for their Influvac Quadrivalent Vaccine QIV Program. Abbott India has been making continuous efforts for portfolio expansion launching unique products and leveraging technology for better healthcare outcomes.

Share Price: ₹23537.80 per share as on 29 Nov, 2023 04:01 PM
Market Capitalisation: ₹50,357.72Cr as of today
Listing date: 03 Nov, 1994
Chairperson Name: Munir Shaikh
OrganisationAbbott India Ltd
E-voting on sharesClick here to vote

Fundamentals of Abbott India Ltd

Insights on Abbott India Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.


    MF Holding Up


    Mutual Funds have increased holdings from 7.27% to 7.32% in Sep 2023 quarter


    Price Rise


    In the last 3 years, ABBOTINDIA stock has moved up by 53.9%

  • imgNO EFFECT

    Against Peers


    In the last 1 year, Dr Reddys Laboratories Ltd has given 27.5% return, outperforming this stock by 10.0%

  • imgNO EFFECT

    Against Peers


    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 120.9% return, outperforming this stock by 67.0%

  • imgNO EFFECT

    Promoter Holding Unchanged


    Promoters holdings remained unchanged at 74.99% of holdings in Sep 2023 quarter


    Retail Holding Down


    Retail Investor have decreased holdings from 16.04% to 16.00% in Sep 2023 quarter


    FII Holding Down


    Foreign Institutions have decreased holdings from 0.19% to 0.18% in Sep 2023 quarter

Abbott India Ltd Mutual Fund Holdings

Funds Holdings
Axis Midcap Fund Direct Plan GrowthAxis Midcap Fund Direct Plan Growth1.68%
SBI Large & Midcap Fund Direct GrowthSBI Large & Midcap Fund Direct Growth1.83%
Canara Robeco Emerging Equities Direct Plan Growth OptionCanara Robeco Emerging Equities Direct Plan Growth Option1.44%
SBI Magnum Global Fund Direct GrowthSBI Magnum Global Fund Direct Growth4.03%
PGIM India Midcap Opportunities Fund Direct GrowthPGIM India Midcap Opportunities Fund Direct Growth2.47%

Abbott India Ltd Shareholding Pattern

InvestorsHoldings %Prev. 3 periods3M change
Promoter Holdings
Foreign Institutions
Mutual Funds
Retail Investors

Technicals of Abbott India Ltd share

News & Events of Abbott India Ltd

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Abbott India Ltd shares.

Abbott India Ltd (ABBOTINDIA) share price today is ₹23537.8

Abbott India Ltd is listed on NSE

Abbott India Ltd is listed on BSE

  • Today’s highest price of Abbott India Ltd is ₹23779.75.
  • Today’s lowest price of Abbott India Ltd is ₹23500.

Today’s traded volume of Abbott India Ltd(ABBOTINDIA) is 5,327.00.

Today’s market capitalisation of Abbott India Ltd(ABBOTINDIA) is ₹50357.72Cr.

Abbott India Ltd(ABBOTINDIAPrice
52 Week High
52 Week Low

Abbott India Ltd(ABBOTINDIA) share price is ₹23537.8. It is down -4.88% from its 52 Week High price of ₹24744.25

Abbott India Ltd(ABBOTINDIA) share price is ₹23537.8. It is up 18.28% from its 52 Week Low price of ₹19900

Abbott India Ltd(ABBOTINDIAReturns
1 Day Returns
1 Month Returns
3 Month Returns
1 Year Returns